Pharmaceutical composition for reducing the symptoms and disease of the respiratory infection caused by human metapneumovirus (HMPV), which comprises at least one agent that neutralises the function of the TSLP and/or TSLPR and/or OX40L and/or CD177 molecules, and a pharmaceutically acceptable excipient, and the use thereof (Australia, concesión n° 2016402264)
dc.catalogador | jca | |
dc.contributor.author | Kalergis Parra, Alexis Mikes | |
dc.contributor.author | Bueno Ramírez, Susan Marcela | |
dc.contributor.author | Lay, Margarita K. | |
dc.date.accessioned | 2025-05-07T16:47:59Z | |
dc.date.available | 2025-05-07T16:47:59Z | |
dc.date.concesion | 05-12-2024 | |
dc.date.created | 15-11-2018 | |
dc.description | Patente de invención | |
dc.estado.patente | CONCEDIDA | |
dc.fuente.origen | Propiedad intelectual | |
dc.identifier.UA | Facultad de Ciencias Biológicas | |
dc.identifier.concesion | 2016402264 | |
dc.identifier.govdoc | 2016402264 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/104069 | |
dc.information.autoruc | Facultad de Ciencias Biológicas; Kalergis Parra, Alexis Mikes; 0000-0001-7622-5263; 90610 | |
dc.information.autoruc | Facultad de Ciencias Biológicas; Bueno Ramirez, Susan Marcela; 0000-0002-7551-8088; 113541 | |
dc.information.autoruc | Facultad de Ciencias Biológicas; Lay, Margarita K.; S/I; 90429 | |
dc.language.iso | en | |
dc.nota.acceso | sin adjunto | |
dc.pais | Australia | |
dc.presentacion | Extranjera no prioridad | |
dc.rights | registro bibliográfico | |
dc.solicitante | Pontificia Universidad Católica de Chile | |
dc.subject | Salud | |
dc.subject | Tratamientos de enfermedades infecciosas | |
dc.subject.ddc | 608 | |
dc.subject.dewey | Tecnología | es_ES |
dc.territorialidad | Extranjera | |
dc.title | Pharmaceutical composition for reducing the symptoms and disease of the respiratory infection caused by human metapneumovirus (HMPV), which comprises at least one agent that neutralises the function of the TSLP and/or TSLPR and/or OX40L and/or CD177 molecules, and a pharmaceutically acceptable excipient, and the use thereof (Australia, concesión n° 2016402264) | |
dc.type | patente | |
sipa.codpersvinculados | 90610 | |
sipa.codpersvinculados | 113541 | |
sipa.codpersvinculados | 90429 |